For decades, cannabis has been locked in a federal legal limbo—classified as a Schedule I drug alongside heroin, deemed to have “no accepted medical use.” But the tide is beginning to turn. In April 2024, the Drug Enforcement Administration (DEA) took initial steps to reclassify marijuana as a Schedule III drug, a category that includes… Read more

The landscape of medical treatment in the United States is evolving rapidly, thanks in large part to major strides in cannabis research. As public attitudes shift and scientific understanding deepens, cannabis is emerging as a powerful tool in modern medicine—offering hope for patients across a wide range of conditions. This article highlights recent breakthroughs in… Read more

More than 10 million people worldwide live with Parkinson’s disease—a progressive neurological disorder that disrupts movement and often brings tremors, stiffness, and balance issues. But emerging research suggests that medical marijuana may offer meaningful relief for many of these individuals. Studies from respected institutions are increasingly pointing to the therapeutic potential of cannabis in managing… Read more

Even as the federal government continues to classify marijuana as a Schedule I substance—defined as having no accepted medical use and a high potential for abuse—multiple U.S. agencies are now quietly contradicting that stance. Most recently, the U.S. Department of Agriculture (USDA) added Cannabis sativa to its plant database with documented “medicinal” uses. The listing… Read more

A coalition of 45 advocacy and medical organizations—including Americans for Safe Access (ASA), the U.S. Pain Foundation, National Multiple Sclerosis Society, Epilepsy Foundation of America, and others—is urging Congress to safeguard state medical cannabis programs in federal spending legislation and to allow federal cannabis rescheduling efforts to proceed. In a letter sent Monday to House… Read more

As more states legalize cannabis for both medical and recreational use, a growing number of Americans living with chronic pain are exploring cannabis as an alternative to traditional pain treatments. This shift is reshaping the landscape of pain management—and sparking new conversations among patients, healthcare providers, and policymakers. Cannabis Use Among Chronic Pain Patients on… Read more

In the long and often frustrating national conversation over federal marijuana reform, a critical legal truth continues to be ignored: the Attorney General (AG) has the authority to unilaterally reschedule marijuana under existing federal law—without any input from Congress, without a drawn-out review by the Department of Health and Human Services (HHS), and without undergoing… Read more

Marseille, France — A growing body of anecdotal and observational evidence continues to highlight the potential benefits of cannabis for individuals living with Parkinson’s disease (PD). Now, new survey data published in the peer-reviewed journal Parkinson’s Disease reveals that a significant number of French patients with PD who use cannabis report improvements in both their… Read more

Cannabis culture has undergone a dramatic transformation in recent years, driven largely by a wave of legalization across numerous countries and U.S. states. What was once a taboo subject is now at the center of mainstream policy, business, and public health discussions. This article explores the far-reaching effects of cannabis legalization, examining its influence on… Read more

Contrary to the old stoner stereotypes, scientists now believe that cannabis—specifically low doses of THC—could actually sharpen cognitive function as we age. In a groundbreaking study published in Nature Medicine, researchers from the University of Bonn and the Hebrew University of Jerusalem found that small, regular doses of tetrahydrocannabinol (THC)—the psychoactive compound in cannabis—can significantly… Read more